STAT

LISTEN: Biotech’s six months of surprise, the shaky road ahead, and sell-side self-doubt

Why is everyone so down on biotech's household names? And if a stock gets downgraded in an analyst note, should anyone care? Find out on "The Readout LOUD."

Why is everyone so down on biotech’s household names? How do you become a day trader? And if a stock gets downgraded in

You're reading a preview, sign up to read more.

More from STAT

STAT3 min read
Experimental Brain-controlled Hearing Aid Can Pick Out Voices In A Crowd
Researchers unveiled an experimental hearing aid that reads the mind, using artificial intelligence to separate the sounds of different speakers.
STAT3 min readSociety
A Smartphone App Could Help Diagnose Ear Infections More Accurately — And At Home
With a paper funnel and machine learning, a new smartphone app could help determine at home whether a child has an ear infection.
STAT4 min readSociety
Pharma Is Making Progress Addressing Global Health, But It’s Still A Mixed Bag
Drug makers are taking steps to reach people on very low incomes, but access programs are for just a few diseases.